KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Merck (MRK) Receivables - Other (2016 - 2023)

Merck (MRK) has disclosed Receivables - Other for 12 consecutive years, with $473.0 million as the latest value for Q1 2023.

  • On a quarterly basis, Receivables - Other fell 34.21% to $473.0 million in Q1 2023 year-over-year; TTM through Mar 2023 was $473.0 million, a 34.21% decrease, with the full-year FY2022 number at $511.0 million, down 46.99% from a year prior.
  • Receivables - Other was $473.0 million for Q1 2023 at Merck, down from $511.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.6 billion in Q2 2021 to a low of $473.0 million in Q1 2023.
  • A 3-year average of $860.4 million and a median of $684.0 million in 2022 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: tumbled 59.5% in 2022, then tumbled 34.21% in 2023.
  • Merck's Receivables - Other stood at $964.0 million in 2021, then tumbled by 46.99% to $511.0 million in 2022, then decreased by 7.44% to $473.0 million in 2023.
  • Per Business Quant, the three most recent readings for MRK's Receivables - Other are $473.0 million (Q1 2023), $511.0 million (Q4 2022), and $567.0 million (Q3 2022).